Literature DB >> 30543614

Reducing the impact of the impending myopia epidemic in New Zealand.

Alexander David Petty1, Graham Wilson2.   

Abstract

Myopia is an eye condition that is increasing around the world, reaching epidemic levels in many countries. It is associated with a higher risk of other ocular diseases including myopic maculopathy and retinal detachment. Historically in New Zealand myopia has existed at a low level, however the environmental changes that have increased myopia internationally will affect New Zealanders too. Higher levels of myopia will have a profound social, economic and health burden on our country. Fortunately, proven interventions to limit the onset and degree of myopia already exist. To limit the level of myopia in New Zealand we propose the creation of a multidisciplinary myopia action group (NZMAG). The NZMAG will serve to support local research, raise awareness of the condition and its associated pathologies, facilitate access to myopia control treatments, improve identification of at-risk children via screening programs, and serve as the guiding body for myopia-related information. With prompt action now, the myopia epidemic seen in other countries can be reduced in New Zealand.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30543614

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  2 in total

1.  Prevalence of refractive errors in Hungary reveals three-fold increase in myopia.

Authors:  János Németh; Tennó Daiki; Gergely Dankovics; István Barna; Hans Limburg; Zoltán Zsolt Nagy
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

2.  Photorefraction Screening Plus Atropine Treatment for Myopia is Cost-Effective: A Proof-of-Concept Markov Analysis.

Authors:  Chuen Yen Hong; Matt Boyd; Graham Wilson; Sheng Chiong Hong
Journal:  Clin Ophthalmol       Date:  2022-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.